טוען...
TREM2 maintains microglial metabolic fitness in Alzheimer’s disease
Elevated risk of developing Alzheimer’s disease (AD) is associated with hypomorphic variants of TREM2, a surface receptor required for microglial responses to neurodegeneration, including proliferation, survival, clustering and phagocytosis. How TREM2 promotes such diverse responses is unknown. Here...
שמור ב:
| הוצא לאור ב: | Cell |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2017
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5573224/ https://ncbi.nlm.nih.gov/pubmed/28802038 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cell.2017.07.023 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|